Makes software that drug makers use to run medicine trials and sales.
New: first time
Giverny Capital bought Veeva for the first time between April and June: 94,956 shares, worth about $17 million. That’s already less than $1 of every $100 they have in stocks.
Mar 31
None
Jun 30
94,956
The numbers
Shares they own
94,956
Value on Jun 30, 2026
$16,851,841
about $17 million
Share of their money
0.6%
less than $1 of every $100 · 32nd of 49
Price per share on Jun 30
$177.47
Kind
Shares
More about Veeva ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.